Wolverine Asset Management’s AstraZeneca AZN Stock Holding History

Wolverine Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,872	Closed	-$344K	–	1703
2025 Q4	$344K	Hold	1,872	–	–	﹤0.01%	1012
2025 Q3	$287K	Hold	1,872	–	–	﹤0.01%	957
2025 Q2	$262K	Hold	1,872	–	–	﹤0.01%	994
2025 Q1	$275K	Hold	1,872	–	–	﹤0.01%	962
2024 Q4	$245K	Hold	1,872	–	–	﹤0.01%	994
2024 Q3	$292K	Hold	1,872	–	–	﹤0.01%	970
2024 Q2	$292K	Hold	1,872	–	–	﹤0.01%	939
2024 Q1	$254K	Hold	1,872	–	–	﹤0.01%	925
2023 Q4	$252K	Hold	1,872	–	–	﹤0.01%	1017
2023 Q3	$253K	Hold	1,872	–	–	﹤0.01%	1015
2023 Q2	$268K	Hold	1,872	–	–	﹤0.01%	957
2023 Q1	$260K	Hold	1,872	–	–	﹤0.01%	994
2022 Q4	$254K	Hold	1,872	–	–	﹤0.01%	1098
2022 Q3	$205K	Hold	1,872	–	–	﹤0.01%	1239
2022 Q2	$247K	Hold	1,872	–	–	﹤0.01%	1149
2022 Q1	$248K	Hold	1,872	–	–	﹤0.01%	1122
2021 Q4	$218K	Hold	1,872	–	–	﹤0.01%	1206
2021 Q3	$224K	Buy	+1,872	New	+$218K	﹤0.01%	1150
2020 Q4	–	Sell	-1,870	Closed	-$204K	–	1637
2020 Q3	$204K	Hold	1,870	–	–	﹤0.01%	974
2020 Q2	$197K	Hold	1,870	–	–	﹤0.01%	935
2020 Q1	$167K	Hold	1,870	–	–	﹤0.01%	941
2019 Q4	$186K	Hold	1,870	–	–	﹤0.01%	983
2019 Q3	$166K	Hold	1,870	–	–	﹤0.01%	1036
2019 Q2	$154K	Hold	1,870	–	–	﹤0.01%	1073
2019 Q1	$151K	Hold	1,870	–	–	﹤0.01%	1075
2018 Q4	$142K	Sell	1,870 -123	-6%	-$9.61K	﹤0.01%	1300
2018 Q3	$157K	Sell	1,993 -800	-29%	-$60.5K	﹤0.01%	1221
2018 Q2	$196K	Sell	2,793 -200	-7%	-$14.4K	﹤0.01%	1108
2018 Q1	$209K	Buy	+2,993	New	+$207K	﹤0.01%	1141
2016 Q4	–	Sell	-3,220	Closed	-$183K	–	1176
2016 Q3	$211K	Hold	3,220	–	–	﹤0.01%	860
2016 Q2	$194K	Hold	3,220	–	–	﹤0.01%	874
2016 Q1	$181K	Hold	3,220	–	–	0.01%	682
2015 Q4	$218K	Hold	3,220	–	–	﹤0.01%	840
2015 Q3	$204K	Hold	3,220	–	–	﹤0.01%	908
2015 Q2	$205K	Sell	3,220 -1,380	-30%	-$94.5K	﹤0.01%	897
2015 Q1	$314K	Buy	+4,600	New	+$320K	0.01%	743
2014 Q4	–	Sell	-1,380	Closed	-$98K	–	2162
2014 Q3	$98K	Buy	+1,380	New	+$101K	﹤0.01%	1309
2014 Q1	–	Sell	-1,380	Closed	-$81K	–	2410
2013 Q4	$81K	Sell	1,380 -7,520	-84%	-$409K	﹤0.01%	1542
2013 Q3	$462K	Buy	8,900 +3,200	+56%	+$161K	0.01%	789
2013 Q2	$269K	Buy	+5,700	New	+$290K	0.01%	1000

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Wolverine Asset Management's AZN Position: Q1 2026 in Review

Wolverine Asset Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,872 shares — an estimated $344K sold.

Wolverine Asset Management first reported a position in AZN in Q2 2013 and held it in 40 quarters. The position peaked at $462K in Q3 2013. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Wolverine Asset Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Wolverine Asset Management sold 1,872 AstraZeneca shares in Q1 2026, an estimated $344K.
Wolverine Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 40 quarters.
Wolverine Asset Management's AstraZeneca position peaked at $462K in Q3 2013.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.